West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services (NYSE: WST) has announced its participation in three upcoming investor conferences in November 2024. The company will present at the UBS Global Healthcare Conference in California on November 12 at 3:30 PM PST, the Jefferies Healthcare Conference in London on November 19 at 1:00 PM GMT, and the Stephens Annual Investment Conference in Nashville on November 21 at 10:00 AM CST.
Live audio webcasts will be available on the company's website investor section, with replays accessible for approximately 90 days following each event.
West Pharmaceutical Services (NYSE: WST) ha annunciato la sua partecipazione a tre conferenze per investitori che si terranno a novembre 2024. L'azienda presenterà alla Conferenza Globale sulla Salute UBS in California il 12 novembre alle 15:30 PST, alla Conferenza sulla Salute Jefferies a Londra il 19 novembre alle 13:00 GMT, e alla Conferenza annuale sugli investimenti Stephens a Nashville il 21 novembre alle 10:00 CST.
Le webcasts audio in diretta saranno disponibili nella sezione investitori del sito web dell'azienda, con repliche accessibili per circa 90 giorni dopo ciascun evento.
West Pharmaceutical Services (NYSE: WST) ha anunciado su participación en tres conferencias para inversores que se llevarán a cabo en noviembre de 2024. La compañía presentará en la Conferencia Global de Salud de UBS en California el 12 de noviembre a las 3:30 PM PST, en la Conferencia de Salud de Jefferies en Londres el 19 de noviembre a la 1:00 PM GMT, y en la Conferencia Anual de Inversiones de Stephens en Nashville el 21 de noviembre a las 10:00 AM CST.
Las transmisiones web de audio en vivo estarán disponibles en la sección de inversores del sitio web de la compañía, con repeticiones accesibles durante aproximadamente 90 días después de cada evento.
West Pharmaceutical Services (NYSE: WST)는 2024년 11월에 개최되는 세 개의 투자자 회의에 참여한다고 발표했습니다. 이 회사는 11월 12일 오후 3시 30분 PST에 캘리포니아에서 열리는 UBS 글로벌 헬스케어 회의, 11월 19일 오후 1시에 런던에서 열리는 제프리스 헬스케어 회의, 11월 21일 오전 10시에 내슈빌에서 열리는 스티븐스 연례 투자 회의에서 발표할 예정입니다.
라이브 오디오 웹캐스트는 회사 웹사이트의 투자자 섹션에서 제공되며, 각 이벤트 이후 약 90일 동안 재생이 가능합니다.
West Pharmaceutical Services (NYSE: WST) a annoncé sa participation à trois conférences pour investisseurs qui se tiendront en novembre 2024. L'entreprise présentera à la Conférence mondiale sur la santé UBS en Californie le 12 novembre à 15h30 PST, à la Conférence sur la santé Jefferies à Londres le 19 novembre à 13h00 GMT, et à la Conférence annuelle d'investissement Stephens à Nashville le 21 novembre à 10h00 CST.
Des webcasts audio en direct seront disponibles dans la section investisseur du site web de l'entreprise, avec des rediffusions accessibles pendant environ 90 jours après chaque événement.
West Pharmaceutical Services (NYSE: WST) hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im November 2024 angekündigt. Das Unternehmen wird am 12. November um 15:30 Uhr PST auf der UBS Global Healthcare Conference in Kalifornien, am 19. November um 13:00 Uhr GMT auf der Jefferies Healthcare Conference in London und am 21. November um 10:00 Uhr CST auf der Stephens Annual Investment Conference in Nashville präsentieren.
Live-Audio-Webcasts werden im Investorenbereich der Unternehmenswebsite verfügbar sein, mit Aufzeichnungen, die etwa 90 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
- UBS Global Healthcare Conference in Rancho Pablos Verdes,
California , on November 12, 2024 at 3:30 PM PST - Jefferies Healthcare Conference in London, UK on Tuesday, November 19, 2024 at 1:00 PM GMT
- Stephens Annual Investment Conference in
Nashville, TN on Thursday, November 21, 2024 at 10:00 AM CST
A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302289363.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What investor conferences will West Pharmaceutical Services (WST) attend in November 2024?
How can investors access West Pharmaceutical Services (WST) conference presentations in November 2024?
When is West Pharmaceutical Services (WST) presenting at the UBS Global Healthcare Conference 2024?